COVID-19 Coronavirus

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Recommends COVID-19 Boosters For Kids Ages 5-11 The U.S. Centers for Disease Control and Prevention recommended the COVID-19 vaccine booster for children ages 5 to 11 years after at...

The Centers for Disease Control and Prevention recommended that children ages 5 to 11 receive the newly authorized COVID-19 booster shot from Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX). Following the recommendation, many of the nation's doctors,...

The U.S. National Institutes of Health and Pfizer Inc (NYSE: PFE) are discussing testing a longer course of COVID-19 antiviral treatment Paxlovid, required to prevent reinfections, White House Chief Medical Officer Anthony Fauci said. "We're going to be planning what...

Amid rising concerns over the potential development of resistance to Pfizer Inc's (NYSE: PFE) COVID-19 pill Paxlovid, the company has declined to supply researchers with the antiviral for use in combination studies, according to a Bloomberg report.  Researchers say that...

Immunome Inc (NASDAQ: IMNM) shares are trading higher after it published data demonstrating that its COVID-19 antibody cocktail, IMM-BCP-01, potently cleared the omicron variant (BA.1) when tested in vivo in hamsters.  Additional in vitro testing of a SARS-CoV-2 pseudovirus...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Enanta's RSV Candidate Fails In Low-Risk Patient Population  Enanta Pharmaceuticals Inc's (NASDAQ: ENTA) EDP-938 failed to reduce the total symptom score compared to...

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus FDA Gives Green Signal To Pfizer/BioNTech's COVID-19 Booster For Kids 5-11 Years The FDA has authorized a booster shot of Pfizer Inc (NYSE: PFE) and BioNTech SE's...

Moderna Inc’s (NASDAQ: MRNA) chairman comes forward with a determined defense of the board’s executive hiring process after being forced to fire its new chief financial officer just a day after taking charge. Afeyan said the executive search company contracted by Moderna was also...

The FDA has decided not to authorize fluvoxamine, an antidepressant, to treat COVID-19. The agency that data has not shown the drug to be an effective therapeutic for fighting the virus. "Based on the review of available scientific evidence, the FDA has determined that the data are...

AstraZeneca plc (NASDAQ: AZN) moved to bolster its COVID-19 portfolio of antibodies with a $157 million licensing deal for experimental therapies developed by newly-launched UK-based biotech, RQ Biotechnology Ltd. In addition to the initial sum, AstraZeneca will pay possible...

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus FDA May Authorize Pfizer-BioNTech's COVID-19 Booster For 5-11 Year Kids Soon: NYT The FDA is expected to authorize a booster shot of Pfizer Inc (NYSE: PFE)/BioNTech SE's (...

The FDA has authorized the first nonprescription test to detect Covid-19, influenza, and respiratory syncytial virus (RSV). The test, called the Labcorp Seasonal Respiratory Virus RT-PCR DTC Test, was developed by Laboratory Corp of America Holdings (NYSE: LH). It can be sold...

The FDA is expected to authorize a booster shot of Pfizer Inc (NYSE: PFE) / BioNTech SE's (NASDAQ: BNTX) COVID-19 vaccine for children aged 5 to 11 probably by today, the New York Times reported, citing people familiar with the matter. The companies submitted an...

The European Commission said that no final decision had been made about the possible termination of a contract with Valneva SE (NASDAQ: VALN) to supply its COVID-19 vaccine to the European Union. Earlier today, Valneva said it received a notice of intent from the Commission to...

Valneva SE (NASDAQ: VALN) warned it might have to reconsider its FY22 financial guidance after the European Commission informed the company of its intent to terminate an advance purchase agreement (APA) for its VLA2001 COVID-19 candidate vaccine. In November, the company signed the...